A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer

Recruiting

Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.

Trial locations(18 sites)

United States

Banner MD Anderson Cancer Center (Site 106), Gilbert, Arizona

City of Hope (Site 107), Duarte, California

University of California at Irvine (Site 101), Orange, California

UCLA Medical Center (Site 117), Santa Monica, California

Norton Cancer Institute (Site 115), Louisville, Kentucky